Funding Rounds
Draupnir Bio

Draupnir Bio Seed (2024, $13M)

Draupnir Bio

Developer of oral, small molecule degrades for extracellular disease-causing proteins.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $13.01M

Investors